Skip to main content
Leslie Ellis, MD, Oncology, Winston Salem, NC, Atrium Wake Forest Baptist

LeslieREllisMDMSHPEd, FACP(She/Her)

Oncology Winston Salem, NC

Hematologic Oncology

Associate Professor, Internal Medicine, Bowman Gray School of Medicine of Wake Forest Univ

Dr. Ellis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ellis' full profile

Already have an account?

Summary

  • Dr. Leslie Ellis is an oncologist in Winston-Salem, NC and is affiliated with Wake Forest Baptist Medical Center. She received her medical degree from University of North Carolina School of Medicine and has been in practice 17 years. She specializes in hematologic oncology.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
  • University of Michigan Health System
    University of Michigan Health SystemResidency, Internal Medicine, 2000 - 2003
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 2000

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2006 - 2024

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Evaluating the Utilization of All-Trans Retinoic Acid and Arsenic Trioxide during Consolidation Therapy for Patients Receiving Treatment for Acute Promyelocytic Leukemia
    Leslie Renee Ellis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Selinexor in Combination with Induction and Consolidation Therapy in Older Adults with AML Is Highly ActiveClinically Relevant Abstract
    Leslie Renee Ellis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Career-Development Lunch Sessions: Medical Educators in Hematology 
    60th American Society of Hematology Annual Meeting - 12/1/2018

Press Mentions

  • Benefits with Gilteritinib for AML Were Maintained, Regardless of Co-Mutations
    Benefits with Gilteritinib for AML Were Maintained, Regardless of Co-MutationsJune 4th, 2019

Professional Memberships

Hospital Affiliations